Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Antineoplastics

Docetaxel 114977-28-5

Docetaxel 114977-28-5

Docetaxel is a well-established anti-mitotic chemotherapy medication that works by interfering with cell division. Docetaxel is approved by the FDA for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.Docetaxel can be used as a single agent or in combination with other chemotherapeutic drugs as indicated depending on specific cancer type and stage.

Docetaxel 114977-28-5
Appearance:White powder
Cas No:114977-28-5
EINECS:NA
Formula:C45H55NO15
Molecular Weight:849.92
Melting Point:NA
Boiling Point:901.4 °C
Flash Point: 499 °C
Usage:Antineoplastics

GMP for Docetaxel is available, DMF for Docetaxel can be provided against commercial order
 
Disclaimer:Those products (Docetaxel 114977-28-5) patented are for lab analytical & research purposes only.